Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
RA CAPITAL MANAGEMENT L.P. | 0 0.000% |
-235,110 (Position Closed) |
Filing History |
| 2022-02-14 1:46 pm Purchase |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
345,707 7.530% |
345,707 (New Position) |
Filing History |
| 2022-02-14 06:05 am Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Nikko Asset Management Americas, Inc. | 39,276 0.860% |
-251,904 (-86.51%) |
Filing History |
| 2022-02-11 3:11 pm Purchase |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
252,755 5.500% |
252,755 (New Position) |
Filing History |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
The Vanguard Group | 233,813 5.090% |
233,813 (New Position) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Seres Therapeutics, Inc. MCRB |
FMR LLC | 688,854 14.999% |
122,025 (+21.53%) |
Filing History |
| 2022-02-04 06:09 am Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group Inc. | 39,276 0.850% |
-251,904 (-86.51%) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
293,135 6.400% |
-20,557 (-6.55%) |
Filing History |
| 2022-01-10 10:46 am Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
STATE STREET CORP STT |
239,279 5.210% |
-260,890 (-52.16%) |
Filing History |
| 2021-10-12 12:39 pm Purchase |
2021-09-30 | 13G | Seres Therapeutics, Inc. MCRB |
STATE STREET CORP STT |
500,170 10.910% |
500,170 (New Position) |
Filing History |
| 2021-05-05 4:39 pm Purchase |
2021-04-27 | 13G | Seres Therapeutics, Inc. MCRB |
RA CAPITAL MANAGEMENT L.P. | 235,110 5.100% |
235,110 (New Position) |
Filing History |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
ARK Investment Management LLC | 687,063 15.060% |
72,411 (+11.78%) |
Filing History |
| 2021-02-11 5:26 pm Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Nikko Asset Management Americas, Inc. | 291,180 6.380% |
9,931 (+3.53%) |
Filing History |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Seres Therapeutics, Inc. MCRB |
FMR LLC | 566,829 12.423% |
26,804 (+4.96%) |
Filing History |
| 2021-02-05 06:10 am Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group Inc. | 291,180 6.380% |
9,931 (+3.53%) |
Filing History |
| 2021-02-01 08:30 am Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
313,692 6.900% |
113,524 (+56.71%) |
Filing History |
| 2020-11-25 4:30 pm Sale |
2020-11-23 | 13D | Seres Therapeutics, Inc. MCRB |
Flagship VentureLabs IV LLC | 752,500 16.500% |
-329,846 (-30.48%) |
Filing History |
| 2020-10-09 2:17 pm Purchase |
2020-06-30 | 13G | Seres Therapeutics, Inc. MCRB |
ARK Investment Management LLC | 614,652 13.770% |
250,960 (+69.00%) |
Filing History |
| 2020-09-10 10:03 am Purchase |
2020-09-09 | 13G | Seres Therapeutics, Inc. MCRB |
FMR LLC | 540,025 12.095% |
215,069 (+66.18%) |
Filing History |
| 2020-09-09 06:03 am Sale |
2020-08-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group Inc. | 281,250 6.300% |
-132,412 (-32.01%) |
Filing History |